search
Việt
Hán Việt
Gốc
Dichtienghoa.com không chịu trách nhiệm cho nội dung bên dưới
search
V
HV
G
Dichtienghoa.com không chịu trách nhiệm cho nội dung bên dưới
VIAF
Virtual International Authority File
Search
Select Field:
All Fields
All Headings
Corporate Names
Geographic Names
Personal Names
Works
Expressions
Preferred Headings
Exact Heading
Bibliographic Titles
Select Index:
All VIAF
Argentina
Australia
Belgium (Flemish)
Brazil
Canada
Catalunya
Chile
Croatia
Czech
Denmark (DBC)
Egypt
Estonia
FAST
France (BnF)
France (Sudoc)
Germany
Getty (ULAN)
Greece
Hispánica
Hungary
Iceland
Ireland
ISNI
Israel
Italy
Japan (NDL)
Japan (NII)
Korea
Latvia
Lebanon
LC (NACO)
Lithuania
Luxembourg
Morocco
Netherlands
Norway (BIBSYS)
Norway (National Library)
Iceland
Perseus
Poland (National Library)
Poland (NUKAT)
Portugal
Québec
RILM
RISM
Russia
Singapore
Slovakia
Slovenia
Spain
Sweden
Swiss (National Library)
Swiss (RERO)
Syriac
Taiwan
United Arab Emirates
Vatican
Wikipedia
xA
xR
Search Terms:
Leader
00000nz a2200037n 45 0
001
WKP|Q91472487
(VIAF cluster)
(Authority/Source Record)
003
WKP
005
20241221010900.0
008
241221nneanz||abbn n and d
035
‡a (WKP)Q91472487
024
‡a 0000-0001-9268-5104 ‡2 orcid
035
‡a (OCoLC)Q91472487
100
0
‡a এলিজাবেথ এস ফ্রাঙ্ক ‡9 bn
400
0
‡a Elizabeth S Frank ‡c researcher (ORCID 0000-0001-9268-5104) ‡9 en
400
0
‡a Elizabeth S Frank ‡c wetenschapper ‡9 nl
670
‡a Author's A combination CDK4/6 and IGF1R inhibitor strategy for Ewing sarcoma
670
‡a Author's Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by and activated
670
‡a Author's Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia
909
‡a (orcid) 0000000192685104 ‡9 1
919
‡a resistancemechanismstosykinhibitioninacutemyeloidleukemia ‡A Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia ‡9 1
919
‡a inhibitionofmekandatriseffectiveinabcellacutelymphoblasticleukemiamodeldrivenbyandactivated ‡A Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by and activated ‡9 1
919
‡a combinationcdk46andigf1rinhibitorstrategyforewingsarcoma ‡A A combination CDK4/6 and IGF1R inhibitor strategy for Ewing sarcoma ‡9 1
996
‡2
DNB|1145387772
996
‡2
DNB|1297471369
996
‡2
ISNI|0000000072491372
996
‡2
NTA|075244381
996
‡2
ISNI|0000000070904962
996
‡2
NTA|323582028
996
‡2
ISNI|0000000390601565
996
‡2
RERO|A017113124
996
‡2
DNB|118637061
996
‡2
NTA|073060496
996
‡2
DNB|1157208118
996
‡2
BIBSYS|90083994
996
‡2
SUDOC|251416186
996
‡2
NTA|305354043
996
‡2
NTA|431807132
996
‡2
DNB|1146208758
996
‡2
SUDOC|03027334X
996
‡2
ISNI|0000000388306815
996
‡2
DNB|116700114
996
‡2
BNF|13328013
996
‡2
NDL|00466689
996
‡2
DNB|137630832
996
‡2
DE633|pe41000474
996
‡2
BNF|12034970
996
‡2
NTA|275861538
996
‡2
ISNI|0000000449657951
996
‡2
LC|n 83073128
996
‡2
NTA|314864849
996
‡2
BIBSYS|90180766
996
‡2
J9U|987012370048605171
996
‡2
NTA|435286811
996
‡2
DNB|11670067X
996
‡2
DE633|pe30077959
996
‡2
PLWABN|9810585353405606
996
‡2
NTA|241434890
996
‡2
SUDOC|090312643
996
‡2
ISNI|0000000018133996
996
‡2
PTBNP|1575455
996
‡2
ISNI|0000000057209797
996
‡2
LC|no2020117743
996
‡2
ISNI|0000000387802884
996
‡2
RERO|A003259647
996
‡2
NTA|068938527
996
‡2
BIBSYS|90224677
996
‡2
BNF|16155244
996
‡2
DE633|pe30111594
996
‡2
BNF|16943632
996
‡2
LC|n 2001065420
996
‡2
J9U|987007371304305171
996
‡2
LC|n 86049098
996
‡2
PTBNP|1146904
996
‡2
ISNI|0000000356370361
996
‡2
NTA|317040073
996
‡2
DNB|115797614X
996
‡2
NDL|01036824
996
‡2
LC|no2020136145
996
‡2
LC|no2011074810
996
‡2
LC|nb2014016675
996
‡2
LC|nb2008004691
996
‡2
DNB|1327637502
996
‡2
NTA|126794103
996
‡2
SELIBR|356461
996
‡2
ISNI|0000000005316566
996
‡2
J9U|987007261094405171
996
‡2
RERO|A003259393
996
‡2
ISNI|0000000028568731
996
‡2
DNB|1139199307
996
‡2
DNB|116960711X
996
‡2
ISNI|0000000029250514
996
‡2
ISNI|0000000022861451
996
‡2
LC|no2012046541
996
‡2
DNB|1244951269
996
‡2
ISNI|0000000108862869
996
‡2
NKC|jk01031734
996
‡2
NLA|000041727197
996
‡2
NUKAT|n 2010048033
996
‡2
ISNI|0000000044428659
996
‡2
LC|n 85037380
996
‡2
DNB|1047216876
996
‡2
PLWABN|9810615759305606
996
‡2
NUKAT|n 2009136962
996
‡2
NII|DA01889775
996
‡2
N6I|vtls002477075
996
‡2
NTA|153320583
996
‡2
LC|n 83034794
996
‡2
DNB|117195782
996
‡2
DNB|1146999518
996
‡2
J9U|987007261096305171
996
‡2
CAOONL|ncf10604425
996
‡2
LC|n 90650101
996
‡2
J9U|987007280269505171
996
‡2
LC|n 86116679
996
‡2
NKC|jn19990009442
996
‡2
SUDOC|035665912
996
‡2
DNB|132489732
996
‡2
NUKAT|n 2010075675
996
‡2
LC|no2015071293
996
‡2
DNB|1057219738
996
‡2
N6I|vtls001341704
996
‡2
PTBNP|1173559
996
‡2
PLWABN|9810661839005606
996
‡2
NTA|069568820
996
‡2
ISNI|0000000026665300
996
‡2
LC|n 91006068
996
‡2
DNB|124600719
996
‡2
NLA|000036334887
996
‡2
ISNI|0000000382354568
996
‡2
ISNI|0000000393018375
996
‡2
DNB|125270224
996
‡2
RERO|A011394399
996
‡2
SUDOC|137404344
996
‡2
LC|no2004026399
996
‡2
SUDOC|155552392
996
‡2
BNF|13092078
996
‡2
CAOONL|ncf11006922
996
‡2
LIH|LNB:_u__b_H;=B_v_
996
‡2
BIBSYS|12063407
996
‡2
LC|n 00122728
996
‡2
RERO|A011911547
996
‡2
ISNI|0000000112383414
997
‡a 0 0 lived 0 0 ‡9 1